Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1993 1
1994 1
2000 3
2001 2
2002 2
2004 2
2005 3
2006 1
2007 4
2008 11
2009 3
2010 4
2011 8
2012 9
2013 12
2014 11
2015 7
2016 12
2017 7
2018 7
2019 5
2020 8
2021 21
2022 16
2023 13
2024 13
2025 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

166 results

Results by year

Filters applied: . Clear all
Page 1
Reply.
Felson DT, Lacaille D, LaValley MP, Aletaha D. Felson DT, et al. Among authors: lacaille d. Arthritis Care Res (Hoboken). 2022 Mar;74(3):502-503. doi: 10.1002/acr.24842. Epub 2022 Jan 28. Arthritis Care Res (Hoboken). 2022. PMID: 34931490 No abstract available.
Reply.
Hoque MR, Xie H, Lacaille D, Esdaile JM, Aviña-Zubieta JA. Hoque MR, et al. Among authors: lacaille d. Arthritis Rheumatol. 2023 Nov;75(11):2065-2066. doi: 10.1002/art.42621. Epub 2023 Oct 22. Arthritis Rheumatol. 2023. PMID: 37229791 No abstract available.
Reply.
Felson D, LaValley M, Lacaille D, Aletaha D. Felson D, et al. Among authors: lacaille d. ACR Open Rheumatol. 2022 Mar;4(3):269-270. doi: 10.1002/acr2.11401. Epub 2022 Jan 28. ACR Open Rheumatol. 2022. PMID: 35089654 Free PMC article. No abstract available.
When Should I Get My Next COVID-19 Vaccine? Data From the Surveillance of Responses to COVID-19 Vaccines in Systemic Immune-Mediated Inflammatory Diseases (SUCCEED) Study.
Bowdish DME, Chandran V, Hitchon CA, Kaplan GG, Avina-Zubieta JA, Fortin PR, Larché MJ, Boire G, Gingras AC, Dayam RM, Colmegna I, Lukusa L, Lee JLF, Richards DP, Pereira D, Watts TH, Silverberg MS, Bernstein CN, Lacaille D, Benoit J, Kim J, Lalonde N, Gunderson J, Allard-Chamard H, Roux S, Quan J, Hracs L, Turnbull E, Valerio V, Bernatsky S; SUCCEED Investigative Team. Bowdish DME, et al. Among authors: lacaille d. J Rheumatol. 2024 Jul 1;51(7):721-727. doi: 10.3899/jrheum.2023-1214. J Rheumatol. 2024. PMID: 38621797 Free article.
Hydroxychloroquine shortages during the COVID-19 pandemic.
Mendel A, Bernatsky S, Thorne JC, Lacaille D, Johnson SR, Vinet É. Mendel A, et al. Among authors: lacaille d. Ann Rheum Dis. 2021 Mar;80(3):e31. doi: 10.1136/annrheumdis-2020-217835. Epub 2020 May 20. Ann Rheum Dis. 2021. PMID: 32434820 No abstract available.
Mortality and major adverse cardiovascular events after glucagon-like peptide-1 receptor agonist initiation in patients with immune-mediated inflammatory diseases and type 2 diabetes: A population-based study.
Karacabeyli D, Lacaille D, Lu N, McCormick N, Xie H, Choi HK, Aviña-Zubieta JA. Karacabeyli D, et al. Among authors: lacaille d. PLoS One. 2024 Aug 8;19(8):e0308533. doi: 10.1371/journal.pone.0308533. eCollection 2024. PLoS One. 2024. PMID: 39116084 Free PMC article.
166 results